S

Septerna

46 employees

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Software
Information Technology

Date founded

2022

Funding rounds raised

Total raised

$150M

from 15 investors over 15 rounds

S

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP and Vertex Ventures HC

S

Septerna raised $100M on January 27, 2022

Investors: Catalio Capital Management, Samsara BioCapital, Logos Global Management, LP, Casdin Capital, LLC, The Invus Group and Third Rock Ventures

FAQ